Company / Total Assets
IRADIMED CORP Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$108.8M
FY2025
5-year range
$82.9M / $108.8M
FY2021-FY2025
Trend
+10.6%
vs FY2024
Sector context
#159 of 161
Health Care
What the data says
Among 161 Health Care companies, IRADIMED CORP is in the bottom 1% for total assets. Total Assets has increased for 9 consecutive years, from $37M in FY2016 to $109M in FY2025.
Based on SEC 10-K filings.
$109M in FY2025 with a 5-year CAGR of +8.9%.
Improved from $92M to $109M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +8.4%
- 5-Year CAGR
- +8.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 161This company $108.8M Sector average $14.8B
▼
-99.3% below sector average
Key checks
Key Insights
- IRADIMED CORP's total assets has grown for 9 consecutive years.
- 5-year CAGR of +8.9%, indicating consistent growth.
- In FY2025, total assets increased 10.6% year-over-year.
- Ranks #159 out of 161 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 5.29 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $108.8M | +10.6% |
| FY2024 | $98.3M | +6.7% |
| FY2023 | $92.2M | +7.8% |
| FY2022 | $85.5M | +3.2% |
| FY2021 | $82.9M | +16.6% |
| FY2020 | $71.1M | +6.5% |
| FY2019 | $66.7M | +37.7% |
| FY2018 | $48.4M | +24.2% |
| FY2017 | $39.0M | +4.9% |
| FY2016 | $37.2M | +5.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026